Zhejiang Wecome Pharmaceutical Company Limited (300878.SZ)
CNY 15.65
(4.19%)
CNY 15.65
(4.19%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2023 | -8.03 Million CNY | -116.47% |
| 2022 | 48.81 Million CNY | -49.42% |
| 2021 | 96.49 Million CNY | -28.95% |
| 2020 | 135.81 Million CNY | 7.78% |
| 2019 | 126.01 Million CNY | 43.56% |
| 2018 | 87.77 Million CNY | -7.76% |
| 2017 | 95.15 Million CNY | 17.69% |
| 2016 | 80.85 Million CNY | 61.63% |
| 2015 | 50.02 Million CNY | 141.41% |
| 2014 | 20.72 Million CNY | 4.93% |
| 2013 | 19.74 Million CNY | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 Q2 | -10.14 Million CNY | -141.68% |
| 2024 Q3 | 29.9 Million CNY | 394.84% |
| 2024 Q1 | 24.33 Million CNY | 131.44% |
| 2023 Q2 | 37.09 Million CNY | 34.76% |
| 2023 Q1 | 27.52 Million CNY | 155.62% |
| 2023 FY | -8.03 Million CNY | -116.47% |
| 2023 Q4 | -77.38 Million CNY | -1736.14% |
| 2023 Q3 | 4.72 Million CNY | -87.25% |
| 2022 Q4 | -49.48 Million CNY | -233.95% |
| 2022 Q3 | 36.94 Million CNY | 8.45% |
| 2022 Q2 | 34.06 Million CNY | 48.63% |
| 2022 Q1 | 22.91 Million CNY | 506.81% |
| 2022 FY | 48.81 Million CNY | -49.42% |
| 2021 Q4 | 3.77 Million CNY | -86.95% |
| 2021 Q1 | 20.27 Million CNY | -56.42% |
| 2021 FY | 96.49 Million CNY | -28.95% |
| 2021 Q2 | 43.49 Million CNY | 114.57% |
| 2021 Q3 | 28.94 Million CNY | -33.45% |
| 2020 Q2 | 42.31 Million CNY | 168.96% |
| 2020 Q1 | 15.73 Million CNY | -62.96% |
| 2020 Q3 | 31.25 Million CNY | -26.14% |
| 2020 Q4 | 46.51 Million CNY | 48.84% |
| 2020 FY | 135.81 Million CNY | 7.78% |
| 2019 Q4 | 42.47 Million CNY | 59.82% |
| 2019 FY | 126.01 Million CNY | 43.56% |
| 2019 Q3 | 26.57 Million CNY | -6.7% |
| 2019 Q2 | 28.48 Million CNY | -0.0% |
| 2019 Q1 | 28.48 Million CNY | 0.0% |
| 2018 FY | 87.77 Million CNY | -7.76% |
| 2017 FY | 95.15 Million CNY | 17.69% |
| 2016 FY | 80.85 Million CNY | 61.63% |
| 2015 FY | 50.02 Million CNY | 141.41% |
| 2014 FY | 20.72 Million CNY | 4.93% |
| 2013 FY | 19.74 Million CNY | 0.0% |